Daily News and Research on Health Care Stocks (10/2/2008)
Below is today's Daily News and Research on Health Care Stocks. Click here for historical daily updates.
AMED: Amedisys Closes Transaction to Add Six Home Health Agencies and Purchases Home Health and Hospice Agencies in Washington - Business Wire (Thu 7:00am)
BLUD: New Star Analyst Rankings for IMMUCOR INC - StarMine (Thu 9:25am)
BMY: Bristol-Myers Squibb Appoints Christopher Perley as Devens General Manager - Business Wire (Thu 8:00am)
BMY IMCL LLY: Ahead of the Bell: ImClone gains on buyout chatter - AP (Thu 8:26am)
COV: Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace - Business Wire (Thu 9:00am)
DNA: Forex adds 8 pct to Roche's Genentech bid -Citi - at Reuters (Thu 6:29am)
IMCL: Wall St futures mixed as economic worries persist - at Reuters (Thu 6:20am)
IMCL LLY: Opening slide on tap after dour weekly jobs data - SmallCapInvestor.com (Thu 8:50am)
IMCL LLY: Indications: U.S. stock futures lower amid economy fears - at MarketWatch (Thu 8:40am)
IMCL LLY: Indications: U.S. stock futures lower after Senate vote - at MarketWatch (Thu 7:30am)
JNJ: Walgreen, Rite Aid September same-store sales up - at Reuters (Thu 9:26am)
JNJ: Five Ways to Play the Stock Market's Wild Ride - at CNBC (Thu 7:35am)
DAILY NEWS & RESEARCH ON PHARMACEUTICAL STOCKS - Click here
JNJ: Driving Change in Mental Health Through Science and Community - PR Newswire (Thu 7:13am)
JNJ: UPDATE - Bayer launches Xarelto in EU, cost matches Lovenox - at Reuters (Thu 7:03am)
LLY: Monsanto Company Completes Sale of POSILAC Bovine Somatotropin and Related Business - PR Newswire (Thu 9:00am)
LLY: Before the Bell: Ford, UBS, Eli Lilly, Walgreens in the spotlight - at MarketWatch (Thu 8:42am)
MRK: Merck ends obesity drug study and regulatory plan - AP (Thu 8:45am)
MRK: Merck stops development of obesity treatment - at MarketWatch (Thu 8:16am)
MRK: InPlay: Merck discontinues development of investigational medicine taranabant for obesity - Briefing.com (Thu 8:03am)
MRK: Merck Discontinues Development of Investigational Medicine Taranabant for Obesity - Business Wire (Thu 8:00am)
MRK PFE: UPDATE - Merck ends development of obesity drug taranabant - at Reuters (Thu 8:51am)
MRK PFE: [video] 3 Stocks I Saw on TV - at TheStreet.com (Thu 8:08am)
PRGO: STOCK PICKS: Top 5 Mid-Caps for Oct. 2 - at TheStreet.com (Thu 7:59am)
UNH: Fast Money' Portfolios of the Week - at TheStreet.com (Thu 7:01am)
VAR: Syracuse Radiation Oncology Now Offering Cancer Patients a Faster Form of Ultra-Precise Radiotherapy Using New Technology from Varian Medical Systems - PR Newswire (Thu 8:00am)
Comments